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We read with great interest ‘‘Transient leukoerythroblastosis
in a very low birth weight infant with parvovirus B19 infection’’
by Duran et al.1 The authors describe a preterm infant with
transient leukoerythroblastosis associated with a parvovirus B19
infection.
Parvovirus B19 is a widespread virus, which shows tropism to
bone marrow, particularly erythroid progenitor cells. In immu-
nocompetent children, parvovirus B19 is the cause of erythema
infectiosum. Transient hemolytic crisis is seen in those who have
an underlying hemolytic disease. Parvovirus B19 is also a cause
of cytopenia in children who have a congenital or acquired
immune deﬁciency, such as organ transplant recipients and
cancer patients.2
Leukoerythroblastosis is a rare disease that is characterized by
leukocytosis and the presence of erythroid and myeloid blasts in
the peripheral blood. Themost common causes in children are viral
infections and juvenile myelomonocytic leukemia (JMML). It can
also be observed following osteopetrosis, myeloﬁbrosis, and
neuroblastoma.3–5
We report the case of a 2-month-old baby with a parvovirus
B19 infection who initially presented with features of JMML. The
patient was a twin pair male, born to non-related parents,
weighing 2400 g. The prenatal and birth histories were
unremarkable. He developed vomiting and reduced sucking on
day 3 of life and was admitted to the neonatal intensive care unit
with a diagnosis of sepsis. He was referred to our Pediatric
Gastroenterohepatology Department with a distended abdomen
and hepatosplenomegaly, which developed on follow-up.[(Figure_1)TD$FIG]
Figure 1. Bone marrow aspirate showing myelocytes, hypogranularity, and a blast
(arrow) (Giemsa staining, original magniﬁcation 1000).
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widespread lymphadenomegaly, and no rash. Routine laboratory
measurements showed signiﬁcant leukocytosis (38.5  109/l),
anemia (hemoglobin 9.2 g/dl and hematocrit 27.1%), and
thrombocytopenia (96  109/l). Leukoerythroblastosis, monocy-
tosis, and blast cells were noted in a peripheral blood smear. The
reticulocyte ratio was 9.4%. Hemolytic anemia was ruled out
because a direct Coombs test was negative and his bilirubin
levels were within normal limits. As a viral infection and JMML
were primarily considered, blood samples were sent for
serological studies and TORCH panel (toxoplasmosis, rubella,
cytomegalovirus, herpes simplex virus). A bone marrow aspira-
tion was normocellular; 60% myelomonocytic cells and 3% blasts
were present (Figure 1). Bone marrow cytogenetic examination
was normal, and bcr–abl was negative. The patient’s viral
serology results were positive for anti-parvovirus IgM and IgG.
Intravenous immunoglobulin was started and the patient’s
leukocytes decreased after the ﬁrst dose. The patient is still
on follow-up; repeated blood counts have been normal and the
hepatosplenomegaly has improved.
Leukoerythroblastosis mimicking JMML has been described in
viral diseases such as cytomegalovirus and Epstein–Barr virus
infections.6–8 Only four patients with parvovirus B19 infection
and leukoerythroblastosis have previously been reported in the
literature.1,3,8,9 Our case also shows that parvovirus B19
infection should be considered in the differential diagnosis of
leukocytosis and that intravenous immunoglobulin treatment
may be beneﬁcial.
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